欧洲泌尿外科学会非神经源性男性下尿路症状指南中膀胱活动低下分章节的摘要
欧洲泌尿外科学会非神经源性男性下尿路症状指南小组于2024年版新增膀胱活动低下(UAB)分章节,系统检索2002至2022年文献,按指南办公室方法学给出推荐强度。逼尿肌活动低下(DU)是尿动力学诊断,UAB用于描述DU相关症状;持续残余尿>300ml时推荐间歇导尿优于留置导尿。
要点
- 逼尿肌活动低下是尿动力学诊断,膀胱活动低下用于描述其相关症状与临床特征。
- 持续残余尿>300ml时,推荐间歇导尿,优于留置导尿。
- 推荐α肾上腺素能受体阻滞剂先于更具侵入性的技术,但证据水平低。
核心结论
- 本文为欧洲泌尿外科学会非神经源性男性下尿路症状指南2024年版中膀胱活动低下新分章节的摘要,详细内容参见指南全文。
研究设计与样本
- 欧洲泌尿外科学会非神经源性男性下尿路症状指南小组制定,系统检索2002年至2022年文献,选取最高确定性证据文章,并按指南办公室方法学对每条推荐给出强度评级。
主要发现
- 逼尿肌活动低下被定义为收缩强度减弱和/或持续时间缩短的尿动力学诊断,导致膀胱排空延长和/或无法在正常时间范围内完全排空膀胱。
- 膀胱活动低下这一术语应保留用于描述与逼尿肌活动低下相关的症状和临床特征。
- 侵入性尿动力学是唯一被广泛接受的逼尿肌活动低下诊断方法。
关键数值与推荐
- 对持续残余尿升高(即>300 ml)的患者,有指征行间歇导尿,且优于留置导尿。
- 推荐α肾上腺素能受体阻滞剂先于更具侵入性的技术,但证据水平低。
- 对逼尿肌活动低下合并良性前列腺梗阻的男性,仅在充分告知后考虑良性前列腺手术。
- 对逼尿肌活动低下不合并良性前列腺梗阻的男性,可考虑骶神经调控测试阶段。
临床怎么用
- 持续残余尿>300 ml的患者可行间歇导尿,优于留置导尿。
- 推荐α肾上腺素能受体阻滞剂先于更具侵入性的技术,但证据水平低。
- 逼尿肌活动低下合并良性前列腺梗阻者,仅在充分告知后考虑良性前列腺手术。
- 逼尿肌活动低下不合并良性前列腺梗阻者,可考虑骶神经调控测试阶段。
局限性
- α肾上腺素能受体阻滞剂推荐先于更具侵入性的技术,但证据水平低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: The European Association of Urology (EAU) Guidelines Panel on non-neurogenic male lower urinary tract symptoms (LUTS) aimed to develop a new subchapter on underactive bladder (UAB) in non-neurogenic men to inform health care providers of current best evidence and practice. Here, we present a summary of the UAB subchapter that is incorporated into the 2024 version of the EAU guidelines on non-neurogenic male LUTS. METHODS: A systematic literature search was conducted from 2002 to 2022, and articles with the highest certainty evidence were selected. A strength rating has been provided for each recommendation according to the EAU Guideline Office methodology. KEY FINDINGS AND LIMITATIONS: Detrusor underactivity (DU) is a urodynamic diagnosis defined as a contraction of reduced strength and/or duration, resulting in prolonged bladder emptying and/or failure to achieve complete bladder emptying within a normal time span. UAB is a terminology that should be reserved for describing symptoms and clinical features related to DU. Invasive urodynamics is the only widely accepted method for diagnosing DU. In patients with persistently elevated postvoid residual (ie, >300 ml), intermittent catheterization is indicated and preferred to indwelling catheters. Alpha-adrenergic blockers are recommended before more invasive techniques, but the level of evidence is low. In men with DU and concomitant benign prostatic obstruction (BPO), benign prostatic surgery should be considered only after appropriate counseling. In men with DU and no BPO, a test phase of sacral neuromodulation may be considered. CONCLUSIONS AND CLINICAL IMPLICATIONS: The current text represents a summary of the new subchapter on UAB. For more detailed information, refer to the full-text version available on the EAU website (https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts).
引用
- Baboudjian M, Hashim H, Bhatt N, et al. Summary Paper on Underactive Bladder from the European Association of Urology Guidelines on Non-neurogenic Male Lower Urinary Tract Symptoms. Eur Urol. 2024. PMID: 38644139. doi:10.1016/j.eururo.2024.04.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。